Skip to main content
Andrei Goga, MD, Oncology, San Francisco, CA, UCSF Medical Center

AndreiGogaMDPhD

Oncology San Francisco, CA

Breast Cancer

Professor, Cell & Tissue Biology and Medicine, UCSF

Dr. Goga is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Goga's full profile

Already have an account?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1999 - 2001
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1997

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1999 - 2024
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Elected Member The American Society for Clinical Investigation, 2011

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Aurora Kinase A Drives the Evolution of Resistance to Third-Generation EGFR Inhibitors in Lung Cancer  
    Victoria E Wang, Collin M Blakely, Trever G Bivona, Andrei Goga, Nature
  • Cancer Cells Exploit an Orphan RNA to Drive Metastatic Progression  
    Andrei Goga, MD, Nature

Press Mentions

  • A High-Content Screen Identifies the Vulnerability of MYC-Overexpressing Cells to Dimethylfasudil
    A High-Content Screen Identifies the Vulnerability of MYC-Overexpressing Cells to DimethylfasudilMarch 24th, 2021
  • $3M Award Lays Foundation for New Scientific Collaborations at Parnassus Heights Campus
    $3M Award Lays Foundation for New Scientific Collaborations at Parnassus Heights CampusJanuary 7th, 2021
  • ‘Orphan’ RNAs Make Cancer Deadlier, but Potentially Easier to Diagnose
    ‘Orphan’ RNAs Make Cancer Deadlier, but Potentially Easier to DiagnoseNovember 7th, 2018
  • Join now to see all

Research History

  • Professor, Dept Cell & Tissue Biology and MedicineOncogene Signaling Activation of proto-oncogenes results in alterations of multiple signaling pathways, resulting in the rewiring of cell proliferation, metabolism and small RNA circuits which contribute to the tumorigenic state. We seek to discover new therapies for patients.2015 - Present

Professional Memberships

Hospital Affiliations